BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17330261)

  • 1. Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH.
    Lai LA; Paulson TG; Li X; Sanchez CA; Maley C; Odze RD; Reid BJ; Rabinovitch PS
    Genes Chromosomes Cancer; 2007 Jun; 46(6):532-42. PubMed ID: 17330261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma.
    Albrecht B; Hausmann M; Zitzelsberger H; Stein H; Siewert JR; Hopt U; Langer R; Höfler H; Werner M; Walch A
    J Pathol; 2004 Jul; 203(3):780-8. PubMed ID: 15221937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization.
    Lo KC; Bailey D; Burkhardt T; Gardina P; Turpaz Y; Cowell JK
    Genes Chromosomes Cancer; 2008 Mar; 47(3):221-37. PubMed ID: 18050302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation.
    Wongsurawat VJ; Finley JC; Galipeau PC; Sanchez CA; Maley CC; Li X; Blount PL; Odze RD; Rabinovitch PS; Reid BJ
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):509-16. PubMed ID: 16537709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multistage carcinogenesis in Barrett's esophagus.
    Maley CC
    Cancer Lett; 2007 Jan; 245(1-2):22-32. PubMed ID: 16713672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays.
    Lindblad-Toh K; Tanenbaum DM; Daly MJ; Winchester E; Lui WO; Villapakkam A; Stanton SE; Larsson C; Hudson TJ; Johnson BE; Lander ES; Meyerson M
    Nat Biotechnol; 2000 Sep; 18(9):1001-5. PubMed ID: 10973224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of neoplastic cell lineages in Barrett oesophagus.
    Barrett MT; Sanchez CA; Prevo LJ; Wong DJ; Galipeau PC; Paulson TG; Rabinovitch PS; Reid BJ
    Nat Genet; 1999 May; 22(1):106-9. PubMed ID: 10319873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ
    J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing genetically stable and unstable gastric cancers by microsatellites and array comparative genomic hybridization.
    Vauhkonen H; Vauhkonen M; Sajantila A; Sipponen P; Knuutila S
    Cancer Genet Cytogenet; 2006 Oct; 170(2):133-9. PubMed ID: 17011984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization.
    Vauhkonen H; Vauhkonen M; Sajantila A; Sipponen P; Knuutila S
    Cancer Genet Cytogenet; 2006 Jun; 167(2):150-4. PubMed ID: 16737915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in molecular diagnostics of colorectal cancer by genomic arrays: proposal for a procedural shift in biological sampling and pathological report.
    Castorina S; Barresi V; Luca T; Privitera G; Musso N; Capizzi C; Condorelli DF
    Ital J Anat Embryol; 2010; 115(1-2):39-45. PubMed ID: 21072988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Fontolliet C; Bosman FT; Benhattar J
    Gastroenterology; 2002 Apr; 122(4):1113-21. PubMed ID: 11910361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays.
    Zhou X; Rao NP; Cole SW; Mok SC; Chen Z; Wong DT
    Cancer Genet Cytogenet; 2005 May; 159(1):53-7. PubMed ID: 15860358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.